We found that BRCA2 and RAD51 were significantly upregulated in bladder cancer samples in the TCGA/BLCA RNA-Seq data, and that the expression of BRCA2 significantly correlated with that of RAD51 (Spearman R = 0.63; and p-value < 0.001). The gene discussed is RAD51; the disease is urinary bladder carcinoma.